AlphaStocks
5.6
Consider Buy

MARSH & MCLENNAN COMPANIES, INC. (MRSH)

Financials / Insurance Brokers

S&P 500

$167.28

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#41out of 92 in Financials

Is MARSH & MCLENNAN COMPANIES, INC. a Good Investment in 2026?

MARSH & MCLENNAN COMPANIES, INC. (MRSH) scores 5.6 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates MARSH & MCLENNAN COMPANIES, INC. as Strong (7/9). The Lynch model is the least favorable, rating it Neutral. MARSH & MCLENNAN COMPANIES, INC. currently trades above its estimated fair value of $167, suggesting limited upside at current prices. MARSH & MCLENNAN COMPANIES, INC. ranks #41 out of 92 stocks in the Financials sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E19.9ROE15.2Market Cap81BDiv Yield1.9

Estimated Fair Value

$166.960% above

Trading near estimated fair value.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

7/9

Buffett

Strong

Business quality & competitive moat

Graham

Neutral

100% above fair value

Lynch

Neutral

High PEG — growth premium · Slow Grower

Greenblatt

Attractive

Top 10% (rank 3%)

Frequently Asked Questions

Is MARSH & MCLENNAN COMPANIES, INC. (MRSH) a good investment?
Based on AlphaStocks' composite analysis, MARSH & MCLENNAN COMPANIES, INC. (MRSH) scores 5.6 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Trading near estimated fair value.
What is MARSH & MCLENNAN COMPANIES, INC.'s Piotroski F-Score?
MARSH & MCLENNAN COMPANIES, INC.'s Piotroski F-Score status is Strong. The raw score is 7/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is MRSH overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $167, MRSH appears overvalued. The stock currently trades 0% above its estimated fair value. Trading near estimated fair value.
How does MRSH compare to other Financials stocks?
MARSH & MCLENNAN COMPANIES, INC. ranks #41 out of 92 stocks in the Financials sector, placing it in the top 45% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about MRSH?
AlphaStocks evaluates MRSH using five proven investment models. Piotroski: Strong; Buffett: Strong; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 5.6/10.

Similar Stocks

BFHECPGJHG

Compare MRSH with

MRSH vs BFHMRSH vs ECPGMRSH vs JHG

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer